CT-guided implantation of radioactive 125I seed in advanced non-small-cell lung cancer after failure of first-line chemotherapy

详细信息    查看全文

• 作者：Tao Zhang (1)
  Mingjian Lu (1)
  Sheng Peng (1)
  Weidong Zhang (1)
  Guang Yang (1)
  Zhenyin Liu (1)
  Sristi Singh (1)
  Yadi Yang (1)
  Fujun Zhang (1)
  Fei Gao (1)
  
• 关键词：125I seed ; Interventional ; Brachytherapy ; Localized advanced non ; small ; cell lung cancer ; Chemotherapy
• 刊名：Journal of Cancer Research and Clinical Oncology
• 出版年：2014
• 出版时间：August 2014
• 年：2014
• 卷：140
• 期：8
• 页码：1383-1390
• 全文大小：1,048 KB
• 参考文献：1. Ankem MK, Decarvalho VS, Harangozo AM, Hartanto VH, Perrotti M, Han K, Shih WJ, Malka E, White EC, Maggio R, Ioffreda R, Goldsmith JW, Weiss RE (2002) Implications of radioactive seed migration to the lungs after prostate brachytherapy. Urology 59:555-59 CrossRef
  2. Blair HF, Porter A, Chen QS (2004) In vivo detection of an 125I seed located in the intracardiac region after prostate permanent brachytherapy. Int J Radiat Oncol Biol Phys 58:888-91 CrossRef
  3. Canetta R, Franks C, Smaldone L, Bragman K, Rozencweig M (1987) Clinical status of carboplatin. Oncology (Williston Park) 1:61-0
  4. Carney DN, Hansen HH (2000) Non-small-cell lung cancer—stalemate or progress? N Engl J Med 343:1261-262 CrossRef
  5. D’Addessi A, Racioppi M, Giustacchini M, Alcini A, Alcini E (1995) 125I seeds implantation plus pelvic lymphadenectomy in the management of localized prostate cancer. Minerva Urol Nefrol 47:105-11
  6. Deweese TL, Shipman JM, Dillehay LE, Nelson WG (1998) Sensitivity of human prostatic carcinoma cell lines to low dose rate radiation exposure. J Urol 159:591-98 CrossRef
  7. di Maio M, Gridelli C, Gallo C, Manzione L, Brancaccio L, Barbera S, Robbiati SF, Ianniello GP, Ferrau F, Piazza E, Frontini L, Rosetti F, Carrozza F, Bearz A, Spatafora M, Adamo V, Isa L, Iaffaioli RV, di Salvo E, Perrone F (2004) Prevalence and management of pain in Italian patients with advanced non-small-cell lung cancer. Br J Cancer 90:2288-296
  8. Edelman MJ, Khanwani SL (2001) Advanced non-small cell lung cancer. Curr Treat Options Oncol 2:51-2 CrossRef
  9. Ettinger DS, Kris MG (2001) NCCN: non-small cell lung cancer. Cancer Control 8:22-1
  10. Fletcher GH (1973) Clinical dose response curves of human malignant epithelial tumours. Br J Radiol 46:151
  11. Jassem J (2001) Combined chemotherapy and radiation in locally advanced non-small-cell lung cancer. Lancet Oncol 2:335-42 CrossRef
  12. Joyce F, Burcharth F, Holm HH, Stroyer I (1990) Ultrasonically guided percutaneous implantation of iodine-125 seeds in pancreatic carcinoma. Int J Radiat Oncol Biol Phys 19:1049-052 CrossRef
  13. Kong FM, Ten HR, Schipper MJ, Sullivan MA, Chen M, Lopez C, Kalemkerian GP, Hayman JA (2005) High-dose radiation improved local tumor control and overall survival in patients with inoperable/unresectable non-small-cell lung cancer: long-term results of a radiation dose escalation study. Int J Radiat Oncol Biol Phys 63:324-33 CrossRef
  14. Koritzinsky M, Wouters BG, Amellem O, Pettersen EO (2001) Cell cycle progression and radiation survival following prolonged hypoxia and re-oxygenation. Int J Radiat Biol 77:319-28 CrossRef
  15. Kwa SL, Lebesque JV, Theuws JC, Marks LB, Munley MT, Bentel G, Oetzel D, Spahn U, Graham MV, Drzymala RE, Purdy JA, Lichter AS, Martel MK, Ten HR (1998) Radiation pneumonitis as a function of mean lung dose: an analysis of pooled data of 540 patients. Int J Radiat Oncol Biol Phys 42:1- CrossRef
  16. Langer M, Kijewski P, Brown R, Ha C (1991) The effect on minimum tumor dose of restricting target-dose inhomogeneity in optimized three-dimensional treatment of lung cancer. Radiother Oncol 21:245-56 CrossRef
  17. Monk BJ, Tewari KS, Puthawala AA, Syed AM, Haugen JA, Burger RA (2002) Treatment of recurrent gynecologic malignancies with iodine-125 permanent interstitial irradiation. Int J Radiat Oncol Biol Phys 52:806-15 CrossRef
  18. Moreno-Jimenez M, Aristu J, Lopez-Picazo JM, Ramos LI, Gurpide A, Gomez-Iturriaga A, Valero J, Martinez-Monge R (2008) Dosimetric analysis of the patterns of local failure observed in patients with locally advanced non-small cell lung cancer treated with neoadjuvant chemotherapy and concurrent conformal (3D-CRT) chemoradiation. Radiother Oncol 88:342-50 CrossRef
  19. Morton RF, Jett JR, McGinnis WL, Earle JD, Therneau TM, Krook JE, Elliott TE, Mailliard JA, Nelimark RA, Maksymiuk AW, Et A (1991) Thoracic radiation therapy alone compared with combined chemoradiotherapy for locally unresectable non-small cell lung cancer. A randomized, phase III trial. Ann Intern Med 115:681-86 CrossRef
  20. Nag S, Beyer D, Friedland J, Grimm P, Nath R (1999) American Brachytherapy Society (ABS) recommendations for transperineal permanent brachytherapy of prostate cancer. Int J Radiat Oncol Biol Phys 44:789-99 CrossRef
  21. Nakayama H, Satoh H, Sugahara S, Kurishima K, Tsuboi K, Sakurai H, Ishikawa S, Tokuuye K (2011) Proton beam therapy of Stage II and III non-small-cell lung cancer. Int J Radiat Oncol Biol Phys 81:979-84 CrossRef
  22. Parkin DM, Bray F, Ferlay J, Pisani P (2005) Global cancer statistics, 2002. CA Cancer J Clin 55:74-08 CrossRef
  23. Pignol JP, Rakovitch E, Keller BM, Sankreacha R, Chartier C (2009) Tolerance and acceptance results of a palladium-103 permanent breast seed implant phase I/II study. Int J Radiat Oncol Biol Phys 73:1482-488 CrossRef
  24. Planting A, Helle P, Drings P, Dalesio O, Kirkpatrick A, McVie G, Giaccone G (1996) A randomized study of high-dose split course radiotherapy preceded by high-dose chemotherapy versus high-dose radiotherapy only in locally advanced non-small-cell lung cancer. An EORTC lung cancer cooperative group trial. Ann Oncol 7:139-44 CrossRef
  25. Schulder M, Black PM, Shrieve DC, Alexander ER, Loeffler JS (1997) Permanent low-activity iodine-125 implants for cerebral metastases. J Neurooncol 33:213-21 CrossRef
  26. Sgouros G, Knox SJ, Joiner MC, Morgan WF, Kassis AI (2007) MIRD continuing education: bystander and low dose-rate effects: are these relevant to radionuclide therapy? J Nucl Med 48:1683-691 CrossRef
  27. Shepherd FA, Rodrigues PJ, Ciuleanu T, Tan EH, Hirsh V, Thongprasert S, Campos D, Maoleekoonpiroj S, Smylie M, Martins R, van Kooten M, Dediu M, Findlay B, Tu D, Johnston D, Bezjak A, Clark G, Santabarbara P, Seymour L (2005) Erlotinib in previously treated non-small-cell lung cancer. N Engl J Med 353:123-32 CrossRef
  28. Shimizu T, Saijo N (2003) Common toxicity criteria: version 2.0, an improved reference for grading the adverse reaction of cancer treatment. Nihon Rinsho 61:937-42
  29. Smith IE, O’Brien ME, Talbot DC, Nicolson MC, Mansi JL, Hickish TF, Norton A, Ashley S (2001) Duration of chemotherapy in advanced non-small-cell lung cancer: a randomized trial of three versus six courses of mitomycin, vinblastine, and cisplatin. J Clin Oncol 19:1336-343
  30. Taganyi K (2011) Management of lung cancer-related pain. Orv Hetil 152:1184-191 CrossRef
  31. van Harskamp G, Boven E, Vermorken JB, van Deutekom H, Stam J, Njo KH, Karim AB, Tierie AH, Golding RP, Pinedo HM (1987) Phase II trial of combined radiotherapy and daily low-dose cisplatin for inoperable, locally advanced non-small cell lung cancer (NSCLC). Int J Radiat Oncol Biol Phys 13:1735-738 CrossRef
  32. van Houtte P, Klastersky J, Renaud A, Michel J, Vandermoten G, Nguyen H, Sculier JP, Devriendt J, Mommen P (1988) Induction chemotherapy with cisplatin, etoposide and vindesine before radiation therapy for non-small-cell lung cancer: a randomized study. Antibiot Chemother (1971) 41:131-37
  
• 作者单位：Tao Zhang (1)
  Mingjian Lu (1)
  Sheng Peng (1)
  Weidong Zhang (1)
  Guang Yang (1)
  Zhenyin Liu (1)
  Sristi Singh (1)
  Yadi Yang (1)
  Fujun Zhang (1)
  Fei Gao (1)
  
  1. Department of Medical Imaging and Interventional Radiology, Cancer Center and State Key Laboratory of Oncology in South China, Sun Yat-sen University, 651 Dongfeng Road, East, Guangzhou, 510060, People’s Republic of China
  
• ISSN：1432-1335

文摘

Purpose We investigated implanting computed tomography (CT)-guided 125I seed to treat locally advanced non-small-cell lung cancer (NSCLC) after chemotherapy failure. Methods From January 2005 to July 2010, we recruited 69 patients with locally advanced NSCLC who had each had first-line chemotherapy four to six times but had progressive disease; 34 received 125I seed implantation with second-line chemotherapy (Group A) and 35 received second-line chemotherapy only (Group B). Results Mean follow-up was 32?months (range 5-6?months). Overall 2-year local control rate for existing lung lesions was Group A: 39.9?%; Group B: 12.5?% (P?P?>?0.05). Local 3-, 24-month, and median progression-free survival was Group A: 100 and 79.1?% at 11?months; Group B: 76.5 and 18.7?% at 7.3?months, respectively. The groups did not significantly differ in treatment toxicity. Chest pain remission was Group A: 82.1?% (23/28); Group B: 30.8?% (8/26) (P? Conclusion CT-guided radioactive seed 125I implantation procedure is safe and well tolerated in treating locally advanced NSCLC, with few complications. It has good local control rate and can relieve symptoms without increasing side effects.